Encephalitis clinical trials
The registry lists 281 studies for Encephalitis across more than 10 countries. 53 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 168
- Recruiting
- 39
- Status unknown
- 37
- Not yet recruiting
- 12
- Active, not recruiting
- 9
- Withdrawn
- 8
Phase
- Phase 3
- 49
- Phase 2
- 47
- Phase 4
- 39
- Phase 1
- 18
- Early Phase 1
- 1
Where
- United States
- 52
- France
- 41
- Germany
- 23
- Austria
- 21
- China
- 20
- United Kingdom
- 12
Who runs them
Hospices Civils de Lyon (25) · Pfizer (19) · Valneva Austria GmbH (17) · National Institute of Allergy and Infectious Diseases (NIAID) (11) · Sanofi Pasteur, a Sanofi Company (11) · PATH (7) · Medical University of Vienna (7) · Sanofi (7)
Studies
Recruiting first, then most recently updated. Showing 50 of 281 — search for more.
- Early Neurological Outcome in Pediatric EncephalitisNot yet recruitingNCT07830927
- CoMind Early Feasibility StudyRecruitingNCT063686481 country
- Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)RecruitingNCT017301311 country
- Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.RecruitingNCT07432113Not applicable1 country
- Regulating Emotions and Behaviors After Brain InjuryRecruitingNCT05393492Not applicable1 country
- Recovery Trajectory for Coma and Disorders of ConsciousnessRecruitingNCT076140741 country
- KD Treatment for Super-refractory Status EpilepticusRecruitingNCT07496749Not applicable1 country
- A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric DiseaseRecruitingNCT07093333Phase 21 country
- Genetic and Electrophysiologic Study in Focal Drug-resistant EpilepsiesRecruitingNCT028906411 country
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT048066201 country
- Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesRecruitingNCT073322341 country
- Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech RepublicRecruitingNCT072740461 country
- Clinicolaboratory Predictors of Outcome in Children With EncephalitisNot yet recruitingNCT072418581 country
- Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and MeningoencephalitisEnrolling by invitationNCT071868811 country
- Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephalitisRecruitingNCT03993262Phase 21 country
- The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisRecruitingNCT04372615Phase 23 countries
- MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive ImpairmentNot yet recruitingNCT06177028Phase 2
- Causes of Secondary and Prolonged Fever During Treatment of Bacterial Meningitis and Viral EncephalitisNot yet recruitingNCT06971133
- Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)RecruitingNCT06584045Not applicable1 country
- Tick-borne Encephalitis and Borrelial Antibodies in SerumRecruitingNCT03956446Not applicable1 country
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable1 country
- Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL InflammatorY InsultsRecruitingNCT068527031 country
- Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological PatientsNot yet recruitingNCT068490111 country
- Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2RecruitingNCT05850247Phase 21 country
- A Multicentric Cohort of Autoimmune EncephalitisNot yet recruitingNCT067600911 country
- Risk Prediction Model for Severe Autoimmune EncephalitisNot yet recruitingNCT06697678
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT050171421 country
- Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 EncephalitisRecruitingNCT06510283Phase 21 country
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 11 country
- Herpes Simplex Meningo Encephalitis RecurrenceRecruitingNCT066270101 country
- Longterm Influence of Pediatric Long COVID SyndromeRecruitingNCT055663921 country
- Early Interferon-beta Treatment for West-Nile Virus InfectionRecruitingNCT06510426Phase 21 country
- Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the DiseaseRecruitingNCT06515106Not applicable1 country
- Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU TreatmentNot yet recruitingNCT06456736
- National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaRecruitingNCT064433331 country
- Central Nervous System Infections in DenmarkRecruitingNCT034184411 country
- Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery StageRecruitingNCT06183788Not applicable1 country
- Retrospective Analysis of the French National Cohort of Patients With GAD Antibodies and Cerebellar AtaxiaRecruitingNCT063349001 country
- Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis CollectionRecruitingNCT05198661Not applicable1 country
- Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of ConsciousnessRecruitingNCT062839011 country
- Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic EncephalitisRecruitingNCT062454471 country
- Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long TermRecruitingNCT040039221 country
- Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine ImmunogenicityRecruitingNCT06027801Not applicable1 country
- Primary TBE Vaccination for the ElderlyNot yet recruitingNCT04573205Phase 41 country
- Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune EncephalitisRecruitingNCT052806001 country
- Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated EpilepsyEnrolling by invitationNCT054226641 country
- An Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityRecruitingNCT05568953Phase 21 country
- Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological SyndromesRecruitingNCT057726111 country
- Predicting and Monitoring Outcomes in Autoimmune EncephalitisNot yet recruitingNCT05711563
- Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 in ChildrenRecruitingNCT055767141 country